SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
Syndax Pharmaceuticals Inc
@SNDX_InsiderForm 4 Filing: Metzger Michael A Sells $991,328.975 of $SNDX
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Syndax Pharmaceuticals Inc
Ticker: $SNDX
Transaction Value
$991,328.975
Price/Share: $15.31
transaction date
2026-07-08
Shares: 64,750
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Metzger Michael A, holds the title of Chief Executive Officer at Syndax Pharmaceuticals Inc.
On 2026-07-08, the insider transacted 64,750 shares.The shares were transacted at a weighted average price of $15.31 per share, resulting in a total market-relevant value of $991,328.975.
Executive Summary Summary
Metzger Michael A (Chief Executive Officer) sold $991K of $SNDX
Post-Transaction Position: 484,843 shares
SEC Accession No: 0001193125-26-299803 (CIK: 1507220)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.